Myocarditis has become a flashpoint in debates about COVID vaccines; however, new research suggests this rare heart inflammation is a window into how powerful immune technologies sometimes misfire in ...

One of the most widely known risks linked to the COVID-19 vaccine is myocarditis, especially in young males — and now a new Stanford study has shed some light on why this rare effect can occur.

Stanford researchers identify a two-step immune reaction underlying rare myocarditis cases after mRNA COVID vaccination, primarily in adolescent males and young men. Cases typically resolve quickly ...

A rapid, two-step immune reaction may underlie rare cases of heart inflammation seen after Covid mRNA vaccination, Stanford University researchers found, shedding light on a mechanism that’s fueled ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. While extensive studies have found Covid-19 vaccines to be safe, effective, and to ...

The COVID vaccines have saved millions of lives from a virus that has killed more than seven million people globally. Many safety studies and real-world evidence from billions of doses show that the ...

Stanford scientists may be closing in on an explanation for a rare cardiac side effect experienced by a small number of people a few days after they received a COVID-19 shot. Fewer than 30 people in ...

A genetic variant is likely putting some children suffering with myocarditis—inflammation of the heart muscle—at higher risk of developing heart failure, which can be fatal, according to a study ...

The Biden administration withheld data from the public on the risks of myocarditis from the Covid vaccine, Food and Drug Administration Commissioner Marty Makary claimed Thursday — a bold accusation ...

For decades, U.S. electricity demand was steady, allowing utilities to plan gradual growth and maintain the grid with modest upgrades. That era is over. The convergence of electric vehicles (EVs), ...

The updated 2024-2025 mRNA COVID vaccine from Moderna does not appear to carry the same risk for myocarditis in young adults that the first mRNA COVID vaccines did, suggested research presented at the ...

Recommendations in the new ESC guidelines are largely consistent with those of the 2024 American College of Cardiology (ACC) expert consensus decision pathway on managing myocarditis, and a 2025 joint ...